{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:23:11Z","timestamp":1793240591489,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002736","name":"CURE (Citizens United for Research in Epilepsy)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002736","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Academy of Finland (AP"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.eplepsyres.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T17:16:34Z","timestamp":1499879794000},"page":"18-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy"],"prefix":"10.1016","volume":"136","author":[{"given":"Jari","family":"Nissinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Natunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kanninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana I.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Shatillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Sallinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Ekolle","family":"Ndode-Ekane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asla","family":"Pitk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/cercor\/8.3.269","article-title":"Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons","volume":"8","author":"Aoki","year":"1998","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0028-3908(01)00150-2","article-title":"Differentially altered cerebral metabolism in ischemic rats by \u03b12-adrenoceptor blockade and its relation to improved limb-placing reactions","volume":"42","author":"Barbelivien","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(92)94814-C","article-title":"Quantitative in vitro and ex vivo autoradiography of the alpha-2 adrenoceptor antagonist [3H]atipamezole","volume":"224","author":"Biegon","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.eplepsyres.2017.07.005_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1469-7793.1999.533ac.x","article-title":"Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation","volume":"515","author":"Birder","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/neu.2011.1954","article-title":"Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse","volume":"29","author":"Bolkvadze","year":"2012","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1523\/JNEUROSCI.3966-06.2007","article-title":"Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures","volume":"27","author":"Chen","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0035","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1073\/pnas.1409513111","article-title":"\u03b12A adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12967-015-0554-5","article-title":"Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling","volume":"13","author":"Chi","year":"2015","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.eplepsyres.2017.07.005_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2710.2010.01164.x","article-title":"An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity","volume":"36","author":"Christopoulou","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eplepsyres.2013.06.004","article-title":"CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations","volume":"106","author":"Citraro","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2010.03.061","article-title":"Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice","volume":"637","author":"Comelli","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/HTR.0b013e3181ccc8b4","article-title":"The epidemiology of traumatic brain injury","volume":"25","author":"Corrigan","year":"2010","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pain.2005.03.043","article-title":"Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve","volume":"116","author":"Costa","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2006.09.046","article-title":"Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy","volume":"411","author":"Deshpande","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/neu.2013.3019","article-title":"Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eplepsyres.2009.02.019","article-title":"Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model","volume":"85","author":"Echegoyen","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-8993(85)91135-7","article-title":"Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation","volume":"342","author":"Feeney","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1460-9568.2003.02510.x","article-title":"\u03b12A and \u03b12C-adrenoceptor regulation in the brain: \u03b12A changes persist after chronic stress","volume":"17","author":"Fl\u00fcgge","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0100","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1046\/j.1471-4159.1997.69062616.x","article-title":"Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats","volume":"69","author":"Gobert","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00565-4","article-title":"Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release","volume":"84","author":"Gobert","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0091-3057(97)00324-9","article-title":"Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury","volume":"58","author":"Goldstein","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0115","first-page":"731","article-title":"Pharmacological approach to functional reorganization: the role of norepinephrine","volume":"155","author":"Goldstein","year":"1999","journal-title":"Rev. Neurol. Paris"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMcibr0911499","article-title":"\u03b12A \u2212Adrenergic receptors and type 2 diabetes","volume":"362","author":"Gribble","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/PL00005092","article-title":"Evaluation of the effects of a specific \u03b12-adrenoceptor antagonist, atipamezole, on \u03b11- and \u03b12-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine","volume":"356","author":"Haapalinna","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(95)00744-B","article-title":"\u03b12-Adrenoceptorgonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage","volume":"693","author":"Halonen","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(95)00835-7","article-title":"Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus","volume":"299","author":"Halonen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0003-9993(97)90196-9","article-title":"Risk of seizure recurrence after the first late posttraumatic seizure","volume":"78","author":"Haltiner","year":"1997","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0145","first-page":"25","article-title":"Five years after traumatic brain injury: a study of individual outcomes and predictors of change in function","volume":"19","author":"Hammond","year":"2004","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0150","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.4049\/jimmunol.1400255","article-title":"Prevention of neutrophil extravasation by \u03b12-adrenoceptor-mediated endothelial stabilization","volume":"193","author":"Herrera-Garc\u00eda","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0155","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/ket421","article-title":"A double-blind, randomized, placebo-controlled crossover trial of the \u03b1 2c-adrenoceptor antagonist orm-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis","volume":"53","author":"Herrick","year":"2014","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1471-4159.2011.07261.x","article-title":"activate noradrenaline-mediated glycogen turnover in chick astrocytes","volume":"117","author":"Hutchinson","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0165","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0026-895X(24)13264-6","article-title":"Protean agonism at alpha2A-adrenoceptors","volume":"53","author":"Jansson","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0170","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1523\/JNEUROSCI.18-06-02004.1998","article-title":"A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine","volume":"18","author":"Janumpalli","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(00)00409-X","article-title":"Behavioral effects of the \u03b12-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats","volume":"400","author":"Jolkkonen","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0003-9993(98)90060-0","article-title":"Recovery of arm function in patients with paresis after traumatic brain injury","volume":"79","author":"Katz","year":"1998","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eplepsyres.2010.03.007","article-title":"Association of the severity of cortical damage with the occurrence of spontaneous seizures and hyperexcitability in an animal model of posttraumatic epilepsy","volume":"90","author":"Kharatishvili","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2006.03.012","article-title":"A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats","volume":"140","author":"Kharatishvili","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(95)00410-M","article-title":"Effects of a selective alpha2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo","volume":"285","author":"Laitinen","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/syn.21798","article-title":"Validation of [11C]ORM-13070 as a PET tracer for alpha2c-adrenoceptors in the human brain","volume":"69","author":"Lehto","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0205","first-page":"5","article-title":"Chronic alterations in rat brain \u03b1-adrenoceptors following traumatic brain injury","volume":"7","author":"Levin","year":"1994","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0210","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1476-5381.2010.01163.x","article-title":"Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?","volume":"164","author":"Marklund","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0306-4522(89)90247-9","article-title":"Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model","volume":"28","author":"McIntosh","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuroscience.2009.12.002","article-title":"Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy","volume":"166","author":"Ndode-Ekane","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.eplepsyres.2017.07.005_bib0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/neu.2016.4404","article-title":"Unfolded maps for quantitative analysis of cortical lesion location and extent after traumatic brain injury","volume":"34","author":"Ndode-Ekane","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0230","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.STR.26.4.644","article-title":"Environment influences functional outcome of cerebral infarction in rats","volume":"26","author":"Ohlsson","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3171\/jns.1992.77.4.0607","article-title":"Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury","volume":"77","author":"Okiyama","year":"1992","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.euroneuro.2011.04.004","article-title":"CB1 receptor antagonism\/inverse agonism increases motor system excitability in humans","volume":"22","author":"Oliviero","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0245","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1523\/JNEUROSCI.19-21-09281.1999","article-title":"Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells","volume":"19","author":"Olli-L\u00e4hdesm\u00e4ki","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0250","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00701-015-2512-7","article-title":"Epidemiology of traumatic brain injury in Europe","volume":"157","author":"Peeters","year":"2015","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1527-3458.2005.tb00047.x","article-title":"Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist","volume":"11","author":"Pertovaara","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s13311-014-0260-7","article-title":"Epilepsy related to traumatic brain injury","volume":"11","author":"Pitk\u00e4nen","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eplepsyres.2004.07.005","article-title":"Atipamezole, an \u03b12-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats","volume":"61","author":"Pitk\u00e4nen","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdermsci.2014.04.002","article-title":"Vasoconstriction and anti-inflammatory properties of the selective \u03b1-adrenergic receptor agonist brimonidine","volume":"75","author":"Piwnica","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0275","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0028-3908(00)00182-9","article-title":"An \u03b12-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats","volume":"40","author":"Puurunen","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0285","first-page":"1","article-title":"Dexmedetomidine postconditioning reduces brain injury after brain hypoxia-ischemia in neonatal rats","author":"Ren","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.10131","article-title":"Seasonal changes in the densities of \u03b12-noradrenergic receptors are inversely related to changes in testosterone and the volumes of song control nuclei in male European starlings","volume":"444","author":"Riters","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0295","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2006.08.048","article-title":"Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat","volume":"1119","author":"Roosevelt","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(91)90356-X","article-title":"Enhancement of excitability and inhibitory processes in hippocampal dentate gyrus by noradrenaline: a pharmacological study in awake, freely moving rats","volume":"126","author":"Sara","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0305","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1089\/neu.2005.22.1485","article-title":"Electrical stimulation of the vagus nerve enhances cognitive and motor recovery following moderate fluid percussion injury in the rat","volume":"22","author":"Smith","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0310","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/ANE.0000000000000060","article-title":"Locally injected dexmedetomidine inhibits carrageenin-induced inflammatory responses in the injected region","volume":"118","author":"Sukegawa","year":"2014","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/neu.2005.22.42","article-title":"Lateral fluid percussion brain injury: a 15-year review and evaluation","volume":"22","author":"Thompson","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0320","first-page":"190","article-title":"Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole","volume":"297","author":"Virtanen","year":"1989","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/MN:27:1:99","article-title":"Signaling from cAMP\/PKA to MAPK and synaptic plasticity","volume":"27","author":"Waltereit","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2013.12.026","article-title":"noradrenergic receptor suppressed CaMKII signaling in spinal dorsal horn of mice with inflammatory pain","volume":"724","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0335","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2016.05.055","article-title":"CB1 receptor antagonism prevents long-term hyperexcitability after head injury by regulation of dynorphin-KOR system and mGluR5 in rat hippocampus","volume":"1646","author":"Wang","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2017.07.005_bib0340","doi-asserted-by":"crossref","first-page":"16849","DOI":"10.1038\/srep16849","article-title":"Dexmedetomidine inhibits TLR4\/NF-\u03baB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats","volume":"5","author":"Yao","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117302061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117302061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:37:21Z","timestamp":1760276241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117302061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":68,"alternative-id":["S0920121117302061"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.07.005","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}